{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=COVID-19+vaccine", "query": { "intervention": "COVID-19 vaccine" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 401, "total_pages": 41, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=COVID-19+vaccine&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-29T22:23:10.904Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06650462", "title": "Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19", "Trust" ], "interventions": [ { "name": "Community-led discussion", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Old Dominion University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2024-07-02", "completion_date": "2025-04-01", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 1, "location_summary": "Norfolk, Virginia", "locations": [ { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06650462" }, { "nct_id": "NCT07051031", "title": "COVID-19 Reactogenicity", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Nuvaxovid (NVX-CoV2705)", "type": "DRUG" }, { "name": "mNEXSPIKE mRNA-1283", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Marcel Curlin", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2025-10-01", "completion_date": "2026-06-14", "has_results": false, "last_update_posted_date": "2026-03-04", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT07051031" }, { "nct_id": "NCT06742281", "title": "A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "CVXGA (CVXGA50)", "type": "BIOLOGICAL" }, { "name": "COMIRNATY®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "CyanVac LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 432, "start_date": "2024-12-05", "completion_date": "2026-06-15", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 55, "location_summary": "Anniston, Alabama • Phoenix, Arizona • Chula Vista, California + 44 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "La Palma", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06742281" }, { "nct_id": "NCT06128928", "title": "Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19", "Vaccine" ], "interventions": [ { "name": "REDES", "type": "BEHAVIORAL" }, { "name": "Control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 900, "start_date": "2023-07-08", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06128928" }, { "nct_id": "NCT02151448", "title": "αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface", "Malignant Peritoneal Mesothelioma", "Peritoneal Carcinomatosis" ], "interventions": [ { "name": "DC vaccine", "type": "BIOLOGICAL" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Interferon Alfa-2b", "type": "DRUG" }, { "name": "rintatolimod", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "David Bartlett", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2014-07", "completion_date": "2019-02-18", "has_results": true, "last_update_posted_date": "2020-07-20", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02151448" }, { "nct_id": "NCT02334735", "title": "A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Melanoma" ], "interventions": [ { "name": "DC Vaccine", "type": "BIOLOGICAL" }, { "name": "Montanide Vaccine", "type": "BIOLOGICAL" }, { "name": "Poly-ICLC", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Nina Bhardwaj", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2015-07-01", "completion_date": "2020-07-15", "has_results": false, "last_update_posted_date": "2022-09-15", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02334735" }, { "nct_id": "NCT05095844", "title": "National Vaccine Adverse Event Reporting Survey and Etiology", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COVID-19", "Vaccine Adverse Reaction", "Vaccine Reaction", "Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use", "Corona Virus Infection", "Blood Clot", "Thrombocytopenia", "Neuritis", "Vasculitis", "Influenza", "Guillain-Barré", "GWAS", "Genetic Sequencing" ], "interventions": [ { "name": "vaccinated", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Neuroganics LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "5 Years to 99 Years" }, "enrollment_count": 100000, "start_date": "2022-03-15", "completion_date": "2024-04-01", "has_results": false, "last_update_posted_date": "2022-03-18", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 1, "location_summary": "Northglenn, Colorado", "locations": [ { "city": "Northglenn", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05095844" }, { "nct_id": "NCT07464314", "title": "A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza, Human+COVID-19" ], "interventions": [ { "name": "Investigational mRNA Seasonal Flu/COVID-19 Combination (Flu/COVm) Vaccine", "type": "BIOLOGICAL" }, { "name": "Licensed Seasonal Influenza Vaccine", "type": "BIOLOGICAL" }, { "name": "Licensed COVID-19 Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "65 Years to 85 Years" }, "enrollment_count": 225, "start_date": "2026-03-09", "completion_date": "2027-06-03", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 12, "location_summary": "Anniston, Alabama • Little Rock, Arkansas • Fair Oaks, California + 9 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fair Oaks", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07464314" }, { "nct_id": "NCT05543616", "title": "A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "SARS-CoV-2 Virus", "Severe Acute Respiratory Syndrome Coronavirus 2", "COVID-19" ], "interventions": [ { "name": "Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose", "type": "BIOLOGICAL" }, { "name": "Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 6 microgram dose", "type": "BIOLOGICAL" }, { "name": "Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose", "type": "BIOLOGICAL" }, { "name": "Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose", "type": "BIOLOGICAL" }, { "name": "Variant-adapted BNT162b2 (Omicron XBB.1.5) 6 microgram dose", "type": "BIOLOGICAL" }, { "name": "Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose", "type": "BIOLOGICAL" }, { "name": "Variant-adapted BNT162b2 (Omicron KP.2) 10 microgram dose", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Months to 11 Years" }, "enrollment_count": 4338, "start_date": "2022-09-23", "completion_date": "2026-07-10", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 72, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Anaheim, California + 57 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05543616" }, { "nct_id": "NCT07838038", "title": "Effect of Messaging on Pragmatic Outcomes Within an Integrated Healthcare System", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Covid-19 Vaccination" ], "interventions": [ { "name": "Vaccine choice message", "type": "BEHAVIORAL" }, { "name": "Vaccine choice + platform-framed message", "type": "BEHAVIORAL" }, { "name": "Vaccine choice + HCP trust-framed message", "type": "BEHAVIORAL" }, { "name": "Vaccine choice + reactogenicity-framed message", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1300000, "start_date": "2026-09-28", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-09-29T22:23:10.904Z", "location_count": 1, "location_summary": "Pasadena, California", "locations": [ { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07838038" } ] }